Atea Pharmaceuticals, Inc.
NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS
Last updated:
Abstract:
A hemi-sulfate salt of the structure: ##STR00001## to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.
Status:
Application
Type:
Utility
Filling date:
10 Dec 2020
Issue date:
25 Mar 2021